Hoopoe
Senior Member (Voting Rights)
Some of the commonly proposed explanations for the current lack of funding (of everything):
It seems like a reasonable assumption that effective advocacy would involve trying to find out which of these are most important and trying to address or work around them. But maybe we don't need a customized advocacy strategy and can make good progress just by doing the things other patient groups do.
- Misogynism, because ME/CFS affects more women than men.
- Wessely and others said it's deconditioning and (basically) hypochondria and that's why people don't see a need to do biomedical research into this condition.
- Health authorities don't want to admit (or fear) it's an infectious disease that they can't manage or mismanaged in the past.
- It's seen as too hard a scientific problem.
- The perception that ME/CFS doesn't define anything in particular, caused by flawed and unspecific illness definitions.
- Governments or powerful corporations don't want patients to receive disability benefits / or the private equivalent because there are too many of us and we get sick at young age.
- Ignorance about the illness, and the misconception that it just means being tired a lot of the time.
- Patients face many obstacles to advocacy, like being sick, the illness being underdiagnosed, poverty, not being able to think straight when spending more than a short time on one's feet, previous traumatic encounters with doctors etc.
- The BPS people have spread the word that anyone researching ME will be attacked by hostile patients.
- It's stuck in a vicious cycle of low funding that perpetuates low funding.
- There is no medical speciality that has taken responsibility for it (other than maybe psychiatry).
- Infighting over various aspects, resulting in a divided community and many patient organizations that each do their own thing.
- General lack of public relation skills as well as lack of a professionally managed media strategy.
It seems like a reasonable assumption that effective advocacy would involve trying to find out which of these are most important and trying to address or work around them. But maybe we don't need a customized advocacy strategy and can make good progress just by doing the things other patient groups do.
Last edited: